New agents in which cell-piercing carbon nanotubes are used in conjunction with platinum warheads to combat cancer were unveiled by a professor from the Massachusetts Institute of Technology (MIT).

Professor Stephan J Lippard, Head of the Department of Chemistry at MIT, detailed the new method at Indian Institute of Technology in Bombay as part of a speech on the use and methodology of platinum-based anti-cancer drugs.

The lecture also focussed on the history of the anti-cancer properties of cis-diamminedichloroplatinum(II) and how its potency in treating testicular cancer was discovered, expresspharmaonline.com reports.

Professor Lippard then outlined existing studies of the mechanism of the drugs as well as how compounds have led to the discovery of a range of tumours that can be treated.

As well as conducting extensive research into the covalent cisplatin and related anticancer drugs, Professor Lippard's laboratory also discovered and named the first metallointercalators.

Source:

http://www.expresspharmaonline.com/20071231/market08.shtml

http://gjubilee.iitb.ac.in/stephen.html


Ÿ Adfero Ltd